MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENT
Papatheodoridis G, O'Beirne J, Mistry P, Davidson B, Rolles K, Burroughs A. MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENT. Transplantation 1999, 68: 155-157. PMID: 10428285, DOI: 10.1097/00007890-199907150-00029.Peer-Reviewed Original ResearchConceptsStable liver transplant patientsLiver transplant patientsMajor side effectsTransplant patientsRenal impairmentMycophenolate mofetilSide effectsMycophenolate mofetil monotherapyReduction of cyclosporineSerum creatinine levelsEfficacy of monotherapyCellular rejectionIntravenous courseMaintenance immunosuppressantsMofetil monotherapyMycophenolate monotherapyCreatinine levelsSubtherapeutic levelsMonotherapyPatientsSignificant riskMonthsImpairmentMofetilCyclosporine